Sign Out
Pregnancy: There are no adequate data from the use of sitagliptin in pregnant women. The potential risk for humans is unknown. Due to lack of human data, Xigatin should not be used during pregnancy.
Breast-feeding: It is unknown whether sitagliptin is excreted in human breast milk. Animal studies have shown excretion of sitagliptin in breast milk. Xigatin should not be used during breast-feeding.
Continue with Google